24-Week efficacy and safety results from the adalimumab effectiveness in psoriatic arthritis trial (ADEPT)

被引：0
|
作者：
Mease, PJ
Choy, EHS
Gladman, DD
Ritchlin, CT
Ruderman, EM
Steinfeld, SD
Weinberg, MA
机构：
[1] Univ Washington, Sch Med, Seattle, WA USA
[2] Univ London Kings Coll, London WC2R 2LS, England
[3] Univ Toronto, Toronto, ON, Canada
[4] Univ Rochester, Sch Med & Dent, Rochester, NY USA
[5] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[6] Erasme Univ Hosp, B-1070 Brussels, Belgium
[7] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
RHEUMATOLOGY | 2005年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP5
引用
收藏
页码：I3 / I3
页数：1
相关论文
共 50 条
  • [11] Efficacy and safety of adalimumab in psoriasis and psoriatic arthritis: ongoing results
    Papoutsaki, M
    Bianchi, L
    Chimenti, MS
    Di Stefani, A
    Diluvio, L
    Chimenti, S
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (01)
  • [12] Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study
    Kay, Jonathan
    Jaworski, Janusz
    Wojciechowski, Rafal
    Wiland, Piotr
    Dudek, Anna
    Krogulec, Marek
    Jeka, Slawomir
    Zielinska, Agnieszka
    Trefler, Jakub
    Bartnicka-Maslowska, Katarzyna
    Krajewska-Wlodarczyk, Magdalena
    Klimiuk, Piotr A.
    Lee, Sang Joon
    Bae, Yun Ju
    Yang, Go Eun
    Yoo, Jae Kyoung
    Furst, Daniel E.
    Keystone, Edward
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [13] Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study
    Jonathan Kay
    Janusz Jaworski
    Rafal Wojciechowski
    Piotr Wiland
    Anna Dudek
    Marek Krogulec
    Slawomir Jeka
    Agnieszka Zielinska
    Jakub Trefler
    Katarzyna Bartnicka-Maslowska
    Magdalena Krajewska-Wlodarczyk
    Piotr A. Klimiuk
    Sang Joon Lee
    Yun Ju Bae
    Go Eun Yang
    Jae Kyoung Yoo
    Daniel E. Furst
    Edward Keystone
    Arthritis Research & Therapy, 23
  • [14] The efficacy and safety of adalimumab in psoriatic arthritis
    Ritchlin C.T.
    Current Rheumatology Reports, 2006, 8 (5) : 329 - 329
  • [15] Abatacept in the Treatment of Active Psoriatic Arthritis: 24-Week Results from a Phase III Study
    Mease, P.
    Gottlieb, A. B.
    van der Heijde, D.
    FitzGerald, Oliver
    Johnsen, A.
    Nys, M.
    Banerjee, S.
    Gladman, D.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [16] ABATACEPT IN THE TREATMENT OF ACTIVE PSORIATIC ARTHRITIS: 24-WEEK RESULTS FROM A PHASE III STUDY
    Mease, P.
    Gottlieb, A.
    Van der Heijde, D.
    Fitzgerald, O.
    Johnsen, A.
    Nys, M.
    Banerjee, S.
    Xinos, C.
    Gladman, D.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 23 - 23
  • [17] Safety and efficacy of adalimumab in combination with different doses of methotrexate in patients with psoriatic arthritis: Subanalysis of ADEPT
    Gottlieb, Allice
    Teixeira, Henrique D.
    Varothai, Nupun
    Ganz, Fabiana
    Valdecantos, Wendell C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB268 - AB268
  • [18] Abatacept in the Treatment of Active Psoriatic Arthritis: 24-Week Results from a Phase III Study
    Mease, Philip
    Gottlieb, Alice
    van der Heijde, Desiree
    FitzGerald, Oliver
    Johnsen, Alyssa
    Nys, Marleen
    Banerjee, Subhashis
    Gladman, Dafna
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 926 - 926
  • [19] IMPACT OF METHOTREXATE DOSE ON ADALIMUMAB EFFICACY IN PSORIATIC ARTHRITIS: A SUBANALYSIS OF ADEPT
    Aletaha, D.
    Li, Y.
    Hojnik, M.
    Ganz, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 785 - 785
  • [20] A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naive patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial
    Mease, Philip J.
    Smolen, Josef S.
    Behrens, Frank
    Nash, Peter
    Leage, Soyi Liu
    Li, Lingnan
    Tahir, Hasan
    Gooderham, Melinda
    Krishnan, Eswar
    Liu-Seifert, Hong
    Emery, Paul
    Pillai, Sreekumar G.
    Helliwell, Philip S.
    Naftal, Leonardo
    Hidalgo, Rodolfo Ariel Pardo
    Kerzberg, Eduardo Mario
    Savio, Veronica Gabriela
    Lazaro, Alicia
    Velasco, Benito Jorge
    Verzero, Norma Beatriz
    Asnal, Cecilia Adma
    Mysler, Eduardo Fabian
    Berman, Alberto
    Ariel, Federico Javier
    Rischmueller, Maureen
    Zochling, Jane Margaret
    Bird, Paul A.
    Hall, Stephen
    Ostor, Andrew
    Romas, Evange
    Stummvoll, Georg
    Machold, Klaus
    Spellitz, Peter
    Hanusch, Ursula
    Vanden Berghe, Marc
    Leon, Marc
    Vanhoof, Johan Louis Magda
    Van den Bosch, Filip Eduard Jeanne
    De Vlam, Kurt Leo Francois
    Morin, Frederic
    Bessette, Louis
    Haaland, Derek A.
    Schlemmer, Annette Margrethe
    Kristensen, Lars Erik
    Jarvinen, Pentti
    Peltomaa, Ritva Liisa
    Pirila, Laura
    Vuotila, Jorma
    Lespessailles, Eric
    Goupille, Philippe
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (01) : 123 - 131
12345